These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 2384597)

  • 1. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations.
    Marchesi SL; Conboy J; Agre P; Letsinger JT; Marchesi VT; Speicher DW; Mohandas N
    J Clin Invest; 1990 Aug; 86(2):516-23. PubMed ID: 2384597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein 4.1 deficiency associated with an altered binding to the spectrin-actin complex of the red cell membrane skeleton.
    Lorenzo F; Dalla Venezia N; Morlé L; Baklouti F; Alloisio N; Ducluzeau MT; Roda L; Lefrançois P; Delaunay J
    J Clin Invest; 1994 Oct; 94(4):1651-6. PubMed ID: 7929842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of the membrane skeleton of erythrocytes in hereditary spherocytosis and elliptocytosis: significance of the molecular defect for pathogenesis and clinical severity].
    Eber SW
    Klin Padiatr; 1991; 203(4):284-95. PubMed ID: 1942935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements.
    Conboy J; Marchesi S; Kim R; Agre P; Kan YW; Mohandas N
    J Clin Invest; 1990 Aug; 86(2):524-30. PubMed ID: 2384598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of normal membrane stability to unstable protein 4.1-deficient erythrocyte membranes by incorporation of purified protein 4.1.
    Takakuwa Y; Tchernia G; Rossi M; Benabadji M; Mohandas N
    J Clin Invest; 1986 Jul; 78(1):80-5. PubMed ID: 3722387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability.
    Tchernia G; Mohandas N; Shohet SB
    J Clin Invest; 1981 Aug; 68(2):454-60. PubMed ID: 6894932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell membrane polypeptides under normal conditions and in genetic disorders.
    Delaunay J
    Transfus Clin Biol; 1995; 2(4):207-16. PubMed ID: 8542017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant of erythrocyte membrane skeletal protein band 4.1 associated with hereditary elliptocytosis.
    Garbarz M; Dhermy D; Lecomte MC; Féo C; Chaveroche I; Galand C; Bournier O; Bertrand O; Boivin P
    Blood; 1984 Nov; 64(5):1006-15. PubMed ID: 6487803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 4.1.(-) hereditary elliptocytosis.
    Delaunay J; Alloisio N; Morle L
    Acta Med Port; 1985; 6(7-8):S14-6. PubMed ID: 3832803
    [No Abstract]   [Full Text] [Related]  

  • 10. A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.
    Gallagher PG; Tse WT; Coetzer T; Lecomte MC; Garbarz M; Zarkowsky HS; Baruchel A; Ballas SK; Dhermy D; Palek J
    J Clin Invest; 1992 Mar; 89(3):892-8. PubMed ID: 1541680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain.
    Garbarz M; Lecomte MC; Féo C; Devaux I; Picat C; Lefebvre C; Galibert F; Gautero H; Bournier O; Galand C
    Blood; 1990 Apr; 75(8):1691-8. PubMed ID: 2328319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary elliptocytosis due to both qualitative and quantitative defects in membrane skeletal protein 4.1.
    Conboy JG; Shitamoto R; Parra M; Winardi R; Kabra A; Smith J; Mohandas N
    Blood; 1991 Nov; 78(9):2438-43. PubMed ID: 1932756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of clinical and morphological heterogeneity in hereditary elliptocytosis (HE) with spectrin alpha I variants.
    Lecomte MC; Garbarz M; Gautero H; Bournier O; Galand C; Boivin P; Dhermy D
    Br J Haematol; 1993 Nov; 85(3):584-95. PubMed ID: 8136282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective binding of spectrin to ankyrin in a kindred with recessively inherited hereditary elliptocytosis.
    Zail SS; Coetzer TL
    J Clin Invest; 1984 Sep; 74(3):753-62. PubMed ID: 6236232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic anemia caused by congenital anomalies of the erythrocyte membrane].
    Boivin P
    J Genet Hum; 1986 Nov; 34(5):393-412. PubMed ID: 3540209
    [No Abstract]   [Full Text] [Related]  

  • 16. Canine elliptocytosis due to a mutant beta-spectrin.
    Di Terlizzi R; Gallagher PG; Mohandas N; Steiner LA; Dolce KS; Guo X; Wilkerson MJ; Stockham SL
    Vet Clin Pathol; 2009 Mar; 38(1):52-8. PubMed ID: 19228356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanochemistry of protein 4.1's spectrin-actin-binding domain: ternary complex interactions, membrane binding, network integration, structural strengthening.
    Discher DE; Winardi R; Schischmanoff PO; Parra M; Conboy JG; Mohandas N
    J Cell Biol; 1995 Aug; 130(4):897-907. PubMed ID: 7642705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary elliptocytosis: clinical, morphological and biochemical studies of 38 cases.
    Dhermy D; Garbarz M; Lecomte MC; Féo C; Bournier O; Chaveroche I; Gautero H; Galand C; Boivin P
    Nouv Rev Fr Hematol (1978); 1986; 28(3):129-40. PubMed ID: 3748797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical expression of alpha spectrin mutants in hereditary elliptocytosis.
    Palek J; Coetzer T
    Blood Cells; 1987; 13(1-2):237-50. PubMed ID: 3311220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific alternative splicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin.
    Horne WC; Huang SC; Becker PS; Tang TK; Benz EJ
    Blood; 1993 Oct; 82(8):2558-63. PubMed ID: 8400303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.